|
antagonists Montelukast • Pranlukast • ZafirlukastCombination products Budesonide/formoterol • combivent inhaler 14.7 • Ipratropium/salbutamolThis pharmacology-related article is a stub. You can help Wikipedia by expanding it.Retrieved from.
agonistIdentifiersCAS number combivent inhaler 14.7 ?ATC code ?PubChem ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes InhalationThe combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide combivent inhaler 14.7 salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under combivent inhaler 14.7 trade name Combivent.[hide]v • combivent inhaler 14.7 • eDrugs for obstructive airway diseases: asthma/COPD (R03)Adrenergics, combivent inhaler 14.7 combivent inhaler 14.7 acting ?2-agonists: Salbutamol/Levosalbutamol • Fenoterol • TerbutalineLong acting ?2-agonists (LABA): Bambuterol • Clenbuterol • Formoterol • Salmeterolother: Epinephrine • Isoproterenol • OrciprenalineGlucocorticoids Beclometasone • Budesonide • Ciclesonide • Fluticasone • MometasoneAnticholinergics Ipratropium • TiotropiumMast cell stabilizers Cromoglicate • NedocromilXanthines Aminophylline • Theobromine Aminophylline.
Pharmacology stubs | Bronchodilators.
|
__________________
http://shop-med.org pharma shop
People! Same very simply to find!
__________________
http://shop-med.org pharma shop
People! Same very simply to find!
I can give the additional information.
It is very necessary!
It is very necessary!